Term ends Mar 14, 2027 · High confidence
20-year base term ended Mar 12, 2024
Held by Grünenthal GmbH
Filed Mar 12, 2004 as application 10/798,780 · Granted May 18, 2010
Base term plus 1097 days of patent term adjustment (USPTO delay)
Today
2004
2027
Clock starts
Mar 12, 2004
Mar 12, 2004
Term ends
Mar 14, 2027
Mar 14, 2027
Granted
May 18, 2010
May 18, 2010
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,097
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1097 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 12, 2004, when this application, 10/798,780, was filed | Mar 12, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1097 days, USPTO patent term adjustment record | Mar 14, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 14, 2027 | High confidence |
This family
| US 7,718,640 | this patent Mar 2027 | Mar 2027 |
| US 8,338,395 | In force May 2027 | May 2027 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 22, 2004 Reel 15914, frame 882 | Hubler, Doris; Fricke, Sabine; Ingwersen, Jan-peter; Kuhnz, Wilhelm | Schering Aktiengesellschaft | Assignment of Assignor's Interest |
| Oct 30, 2009 Reel 23450, frame 959 | Bayerschering Pharma AG, Formerly Known as Schering Aktiengesellschaft | Endo Pharmaceuticals Solutions Inc., Formerly Known as Indevus Pharmaceuticals, Inc. | License |
| Feb 13, 2010 Reel 23928, frame 628 | Endo Pharmaceuticals Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Confirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents) |
| Dec 9, 2010 Reel 25456, frame 172 | Endo Pharmaceuticals Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Confirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents) |
| Dec 9, 2010 Reel 25456, frame 778 | JPMorgan Chase Bank, N.A., as Administrative Agent | Endo Pharmaceuticals Inc. | Release of Security Interest Recorded at Reel/Frame 23928/628 |
| Jul 8, 2011 Reel 26561, frame 978 | Endo Pharmaceuticals Inc. | Morgan Stanley Senior Funding, Inc., as Administrative Agent | Security Interest in Exclusively Licensed Patents |
| Jul 12, 2011 Reel 26577, frame 357 | JPMorgan Chase Bank N.A., as Administrative Agent | Endo Pharmaceuticals Inc. | Release of Security Interest in Exclusively Licensed Patents Recorded at Reel/Frame 25456/172 |
| Nov 28, 2012 Reel 29373, frame 170 | Bayer Schering Pharma Aktiengesellschaft | Bayer Pharma Aktiengesellschaft | Change of Name |
| Jun 12, 2013 Reel 30596, frame 123 | Bayer Pharma Aktiengesellschaft | Bayer Intellectual Property GmbH | Change of Name |
| Mar 3, 2014 Reel 32380, frame 157 | Morgan Stanley Senior Funding, Inc., as Administrative Agent | Endo Pharmaceuticals Solutions Inc. | Release of Patent Security Interest in Exclusively Licensed Patents |
| Mar 20, 2014 Reel 32491, frame 620 | Endo Pharmaceuticals, Inc. | Deutsche Bank AG New York Branch, as Collateral Agent | Grant of Security Interest in Licensed Patents |
| Mar 24, 2014 Reel 32513, frame 255 | Morgan Stanley Senior Funding, Inc., as Administrative Agent | Endo Pharmaceuticals Inc. | Corrective Assignment to Correct the Name of Receiving Party in Release of Patent Security Interest in Exclusively Licensed Patents Previously Recorded on Reel 032380 Frame 0157. Assignor(S) Hereby Confirms the Release of Security Interest in Exclusively Licensed Patents.. |
| Apr 29, 2014 Reel 32796, frame 29 | Bayer Schering Pharma Aktiengesellschaft | Bayer Pharma Aktiengesellschaft | Previously Recorded Assignment (on 11/28/2012-029373/0170) Contained the English Language Translation of the Commercial Register. the German Version of the Commercial Register, English Translation and Translator Certificate Now Submitted. |
| Apr 28, 2017 Reel 42362, frame 1 | Deutsche Bank AG New York Branch | Endo Pharmaceuticals, Inc.; Endo Pharmaceuticals Solutions, Inc.; Astora Women's Health Holdings, LLC | Release of Security Interest |
| Apr 28, 2017 reel/frame not recorded | Deutsche Bank AG New York Branch | Endo Pharmaceuticals, Inc. | Release of Security Interest |
| Apr 28, 2017 reel/frame not recorded | Deutsche Bank AG New York Branch | Endo Pharmaceuticals Solutions, Inc. | Release of Security Interest |
| Apr 28, 2017 reel/frame not recorded | Deutsche Bank AG New York Branch | Astora Women's Health Holdings, LLC | Release of Security Interest |
| Jan 23, 2023 Reel 62448, frame 602 | Bayer Intellectual Property GmbH | Grünenthal GmbH | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2027
Term ends Mar 14, 2027. No further fees fall due before then
Note
The 1097 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
69
later US patents cite this one
That is top 10% of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.